Rohypnol â contâd. Rohypnol Overview RohypnolÂ® is a trade name for flunitrazepam, a central nervous system (CNS) depressant that belongs to a class of drugs known as benzodiazepines. Flunitrazepam is also marketed as generic preparations and other trade name products outside of the United States.
(May 2013). An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.
The Illinois Adverse Health Care Events Reporting Law requires an Advisory Council to assist with writing the administrative rule, and to review the Department's recommendations for potential quality improvement practices and modifications to the list of reportable adverse health care events consistent with national standards.